“Inizio Launch Elevate” set to help global pharma maximise product launch potential

Published: 21-Nov-2023

Market-leading commercialisation platform, Inizio, has announced "Inizio Launch Elevate," a connected suite of its best-in-class capabilities designed to accelerate and simplify product launches for global pharma and biotech companies.

Inizio Launch Elevate combines deep market and patient insights, launch strategy expertise, and rigorous cross-functional execution to ensure relentless alignment throughout the product launch process.

Successful launches are underpinned by evidence, data, technology and stakeholder management to navigate the complexity involved in market launch activity.

Inizio’s connected capabilities harness the power of its specialist commercialisation platform to unlock, activate and optimise the value of their clients’ innovations across each pivotal moment of their product launch journey. 

Commenting on Inizio’s product launch expertise, Ryan Quigley, COO of Inizio, said: “Launching a treatment is a high-stakes endeavour that comes with a significant risk of failure and pressure to make the right decisions at each pivotal moment."

"This requires strategic alignment, from regulatory approvals to medical and patient engagement to launch strategy." \

"At Inizio, we are optimally positioned to minimise friction and accelerate our clients’ product launch journeys, ultimately creating and realising value for their treatments in new and existing markets, to the benefit of their stakeholders and patients.”
During the last 2 years, Inizio has become recognised as a product launch powerhouse, collaborating with the biggest names in the business and partnering on 95% of top performing products by revenue in 2022.

In addition, across 2021–2022, Inizio supported more than half of all new US product launches spanning numerous therapy areas.

Of these launches, more than 40% are projected to be blockbuster-performing products between now and 2028, which affords Inizio the privileged position of working on the industry’s highest-value and most innovative assets. 
Quigley added: “I am very proud of our team and track record. We apply the collective experience of more than 11,000 empowered experts operating across 50 countries to our clients’ most complex launch challenges.

We help them break down their product launch barriers and put patients at the heart of their launch journey. Inizio Launch Elevate reaffirms our commitment to offering a connected suite of best-in-class commercialisation capabilities so that more people get the treatments they need, faster.”

Inizio helps clients to navigate each pivotal moment of their product journey, offering a distinctive yet highly complementary set of expert-led support services that will give businesses a commercial edge in a highly competitive marketplace. 

You may also like